AstraZeneca News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

13.06.15	AstraZeneca Records Reduced Serum Uric Acid Levels In Phase III Crystal Study (RTTNews)
04.06.15	BLUE, CELG Fine Tune Deal, Lightlake Cruises Ahead, HALO Shines, CPXX On Track (RTTNews)
03.06.15	Ardelyx Terminates Agreement With AstraZeneca; Regains Rights To Tenapanor (RTTNews)
02.06.15	AstraZeneca Provises Update On Immuno-Oncology Combinations Development Program (RTTNews)
31.05.15	AstraZeneca: AZD9291 Data Shows Over 80% Progression Free At 9 Months (RTTNews)
29.05.15	Lilly And AstraZeneca Collaborate On Immuno-Oncology Trial In Solid Tumors (RTTNews)
26.05.15	AMGN Calls It Quits On Brodalumab, CBMG Rises On Study Data, SKBI Put On Notice (RTTNews)
22.05.15	Amgen To Terminate Participation In Co-development Of Brodalumad (RTTNews)
17.05.15	AstraZeneca Reveals Safety Analyses Data For Movantik (RTTNews)
29.04.15	AstraZeneca : FDA Grants Priority Review For New Indication For BRILINTA (RTTNews)
24.04.15	Pre-market Movers For April 24 (AZN, BIIB, XRX, MSFT, AMZN, GOOGL, SBUX, CMCSA) (RTTNews)
24.04.15	AstraZeneca Q1 Results Top Estimates; Backs 2015 Outlook (RTTNews)
24.04.15	AstraZeneca Q1 Profit Increases; Reiterates 2015 Guidance - Quick Facts (RTTNews)
13.04.15	AstraZeneca To Access Data From PatientsLikeMe For Future Medicine Development (RTTNews)
08.04.15	RGLS Up After Hours, GLYC Has Some Good News, Panther On The Prowl (RTTNews)
02.04.15	Nektar Receives $100 Mln Milestone Payment From AstraZeneca For Movantik Sales (RTTNews)
31.03.15	AstraZeneca Says MOVANTIK Launched In U.S. - Quick Facts (RTTNews)
30.03.15	AstraZeneca: FDA Approves New Administration Option For BRILINTA (RTTNews)
18.03.15	AstraZeneca Announces POSITIVE Late-stage Results For PT003 In COPD (RTTNews)
14.03.15	AstraZeneca Announces Results From PEGASUS-TIMI 54 Study (RTTNews)
18.02.15	Eagle Soars, VBLT Crushed Over Drug Failure, Study Fails To Soothe CLTX (RTTNews)
16.02.15	AstraZeneca: US Court Rules Patent Protecting Pulmicort Respules In US Invalid (RTTNews)
12.02.15	AstraZeneca Agrees To Pay $7.9 Mln To Settle Kickback Allegations (RTTNews)
06.02.15	ACT Does A Balancing Act, HSP Snapped Up, PTLA, RXDX Up After-Hours (RTTNews)
05.02.15	AstraZeneca Q4 Adj. Profit Misses View, To Buy Actavis' Respiratory Drug Unit (RTTNews)
05.02.15	AstraZeneca To Buy Actavis' U.S. Respiratory Portfolio - Quick Facts (RTTNews)
05.02.15	AstraZeneca Loss Narrows In Q4 - Quick Facts (RTTNews)
02.02.15	Ardelyx Reports Results From Phase 2b Trial Of Tenapanor In Hyperphosphatemia (RTTNews)
14.01.15	AstraZeneca: PEGASUS-TIMI 54 Trial Meets Primary Efficacy Endpoint - Quick Facts (RTTNews)
20.12.14	FDA Approves AstraZeneca's Lynparza To Treat Advanced Ovarian Cancer (RTTNews)
10.12.14	INFI Makes A Mark, IRWD For The Long Haul, MOVENTIG Approved In EU (RTTNews)
09.12.14	Nektar Therapeutics Reports Approval Of MOVENTIG In EU - Quick Facts (RTTNews)
09.12.14	AstraZeneca Says MOVENTIG Approved In EU For Opioid-induced Constipation (RTTNews)
08.12.14	Dynavax, AstraZeneca To Advance AZD1419 Into Phase 2a Trial - Quick Facts (RTTNews)
01.12.14	Eli Lilly, AstraZeneca Enroll First Patient Into AMARANTH - Quick Facts (RTTNews)
26.11.14	Psoriasis Drug Trial Meets Goals, Reimbursement Rate For Cologuard Finalized (RTTNews)
26.11.14	Amgen,AstraZeneca Report Positive Results From Phase 3 Study Of Brodalumab (RTTNews)
24.11.14	AstraZeneca: Duaklir Genuair Gets EU Marketing Authorisation For COPD (RTTNews)
21.11.14	AstraZeneca Announces $200 Mln Expansion At Frederick Biologics Center (RTTNews)
18.11.14	AstraZeneca On Track To Return To Growth By 2017, Confident Of Pipeline (RTTNews)
18.11.14	AstraZeneca Says Strategy On Track To Deliver Sustainable Growth - Quick Facts (RTTNews)
13.11.14	AstraZeneca Begins Development Program For BRILINTA Reversal Agent - Quick Facts (RTTNews)
13.11.14	Isis Pharma, AstraZeneca To Co-Develop Oligonucleotide Delivery Methods (RTTNews)
11.11.14	Amgen Reveals Positive Data For Brodalumab In Patients With Plaque Psoriasis (RTTNews)
06.11.14	AstraZeneca Profit Declines, Lifts Full Year Forecast (RTTNews)
06.11.14	AstraZeneca To Sell Myalept To Aegerion - Quick Facts (RTTNews)
04.11.14	AstraZeneca's MedImmune To Acquire Definiens (RTTNews)
24.10.14	AstraZeneca Ovarian-cancer Drug Gets Positive CHMP Opinion (RTTNews)
29.09.14	AstraZeneca Presents New Data From Investigational Cancer Drug Pipeline At ESMO (RTTNews)
26.09.14	Nektar Therapeutics Says Moventig Gets Positive CHMP Opinion In EU (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

24.12.24		Optimismus in New York: NASDAQ 100 verbucht zum Ende des Dienstagshandels Zuschläge
24.12.24		Börse New York in Grün: NASDAQ 100 steigt nachmittags
24.12.24		AstraZeneca-Aktie dennoch fester: AstraZeneca und Daiichi Sankyo rudern bei EU-Zulassungsantrag für Lungenkrebsmittel zurück
23.12.24		AstraZeneca-Aktie höher: EU-Zulassung für Tagrisso gegen weitere Lungenkrebsform
18.12.24		Schwacher Handel in New York: NASDAQ 100 am Mittwochnachmittag schwächer
04.12.24		Zuversicht in New York: NASDAQ 100 zum Handelsstart freundlich
03.12.24		Starker Wochentag in New York: NASDAQ 100 steigt zum Handelsende
03.12.24		Starker Wochentag in New York: NASDAQ 100 am Nachmittag mit Kursplus

24.12.24

Optimismus in New York: NASDAQ 100 verbucht zum Ende des Dienstagshandels Zuschläge

24.12.24

Börse New York in Grün: NASDAQ 100 steigt nachmittags

24.12.24

AstraZeneca-Aktie dennoch fester: AstraZeneca und Daiichi Sankyo rudern bei EU-Zulassungsantrag für Lungenkrebsmittel zurück

23.12.24

AstraZeneca-Aktie höher: EU-Zulassung für Tagrisso gegen weitere Lungenkrebsform

18.12.24

Schwacher Handel in New York: NASDAQ 100 am Mittwochnachmittag schwächer

04.12.24

Zuversicht in New York: NASDAQ 100 zum Handelsstart freundlich

03.12.24

Starker Wochentag in New York: NASDAQ 100 steigt zum Handelsende

03.12.24

Starker Wochentag in New York: NASDAQ 100 am Nachmittag mit Kursplus

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	28.70	3.50 %	K V
Swiss Life Hldg	708.40	1.26 %	K V
Swiss Re	132.60	1.07 %	K V
Zurich Insur Gr	542.60	0.71 %	K V
Part Grp Hldg	1’234.00	0.33 %	K V
Logitech Intl	74.34	-0.93 %	K V
Givaudan	3’929.00	-0.93 %	K V
CieFinRichemont	136.20	-1.23 %	K V
Sika	212.40	-1.58 %	K V
Geberit	505.80	-1.71 %	K V

Nachrichten zu AstraZeneca PLC (spons. ADRs)

Aktien Top/Flop

AstraZeneca Peer Group Nachrichten

Meistgelesene Nachrichten